Instinct Bio trades on the Nasdaq under the ticker BIOT, with information published regarding the company's status.
1 report, 1 independent
Updated Jul 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Instinct Bio trades on the Nasdaq under the ticker BIOT, with information published regarding the company's status.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Benzinga is reporting on companies that are listed on the Nasdaq stock exchange.Also in this story
- Benzinga Pro data reports on stock activity for Webull, a company related to the Nasdaq exchange.
- Lumentum stock is trading higher on Nasdaq, while Meta declined to comment on a Benzinga inquiry.
- Benzinga reports on Ambarella's stock performance and details insider sales via SEC filings.
The entities involved
Related events
- Trades are taking place on the Nasdaq stock exchange involving HCW Biologics.
- Prima BioMed began trading on the Nasdaq exchange on September 1, 2026.
- BioCryst Pharmaceuticals traded on the NASDAQ electronic stock exchange on September 12, 2026.
- HCW Biologics announced it is listed on the Nasdaq stock exchange.
- BioHarvest Sciences Inc is listed on the Nasdaq stock exchange and is receiving analyst ratings and targets from MarketBeat.